Health Care & Life Sciences » Healthcare Provision | Bioanalytical Systems Inc.

Bioanalytical Systems Inc.

Bioanalytical Systems Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
10.25 M
Public Float
6.93 M
Bioanalytical Systems Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.09
Market Cap
$20.58 M
Shares Outstanding
10.29 M
Public Float
7.19 M

Profile

Address
2701 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.basinc.com
Updated 07/08/2019
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing.

Financials

View All

Gregory C. Davis
Chairman
John E. Sagartz
Independent Director